Back
Citius Oncology Vs. Theriva Biologics Industry Stock Comparison
Sell
45
CTOR
Citius Oncology
Last Price:
1.40
Seasonality Move:
--
Sell
35
TOVX
Theriva Biologics
Last Price:
1.47
Seasonality Move:
-14.26%
Sell
45
Citius Oncology (CTOR)
is a Sell
Is Citius Oncology a Buy, Sell or Hold?
- The current Citius Oncology [CTOR] share price is $1.40. The Score for CTOR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CTOR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $1.49. The Score for TOVX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- TOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CTOR Stock Price Chart
What is Citius Oncology's stock price today?
-
The Citius Oncology share price today is $1.40
The current trend is relatively stagnant and CTOR is experiencing slight selling pressure.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.
CTOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 27.99 | Sell |
Chaikin Money Flow: | -3335 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
TOVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 28.77 | Sell |
Chaikin Money Flow: | -1255793 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.41 - 4.57) | Sell |
Bollinger Bands (100): | (-0.43 - 2.57) | Buy |
CTOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.58 | Sell |
20-day SMA: | 0 | Buy |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 1.53 | Sell |
20-day EMA: | 1.34 | Buy |
50-day EMA: | 0.84 | Buy |
200-day EMA: | 0.27 | Buy |
TOVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.02 | Sell |
20-day SMA: | 3.62 | Sell |
50-day SMA: | 1.85 | Sell |
200-day SMA: | 0.77 | Buy |
8-day EMA: | 2.72 | Sell |
20-day EMA: | 2.99 | Sell |
50-day EMA: | 2.25 | Sell |
200-day EMA: | 1.07 | Buy |
Citius Oncology Earnings Growth & CTOR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Citius Oncology Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Theriva Biologics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |